Need Help?

Targeted bisulfite sequencing

Raw reads from targeted bisulfite sequencing. The SureSelect Methyl-Seq target enrichment system (Agilent Technologies, Inc., CA, USA) was used to prepare bisulfite sequencing libraries from blood DNA samples of lymphoma patients (Ly1, Ly2), healthy family members (Ly8, Ly9, Ly10, Ly11, Ly12, Ly13 and Ly14), baseline controls (Control1-5), DNMT3A mutation carriers (Id5, Id7, Id9, Id11) and their age-matched controls (Id6, Id8, Id10, Id12). In addition, blood DNA sample of a patient (HLRCC_N7) with germline fumarate hydratase (FH) mutation is included. Illumina paired-end sequencing for targeted libraries from Ly1, Ly2, Ly8, Ly9, Ly10 and Ly11 was done at Karolinska Institutet using 100 base-pair read length and the HiSeq2000 platform. Illumina paired-end sequencing for targeted libraries from Ly12, Ly13, Ly14, and DNMT3A mutation carriers and their age-matched controls was done as a service at BGI (BGI Tech Solutions Co., Ltd., China) using 126 base-pair read length and the HiSeq2500 platform.

Request Access

Data Access Agreement of the study "Molecular Phenotype of Constitutional TET2 Haploinsufficiency in Humans (EGAS00001003454)"

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom UH grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: UH and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean non-commercial research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. UH: University of Helsinki, a public university with its registered address at Fabianinkatu 33, 00014 University of Helsinki, Finland. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify UH within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify UH prior to any significant changes to the protocol for the Project. 14. The User Institution will notify UH as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. UH may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than UH. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. The User Institution agrees that the Data will only be processed and stored within the member states of the European Union. If the country the User Institution is located in ceases to be a member state of the European Union, this agreement shall terminate with immediate effect, and the User Institution will cease the processing of and destroy the Data. 20. The User Institution understands that upon receipt of the Data, it will become a data controller in accordance with the provisions of the General Data Protection Regulation (2016/679) (“GDPR”). The User Institution shall comply with the provisions of the GDPR. UH or its representative may at any moment inform the other User Institution of a Research Participant withdrawing their consent or exercising their rights as a data subject under the GDPR. The User Institution shall perform all actions necessary in order to fulfil the rights of the Research Participant. 21. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Finland and shall be subject to the exclusive jurisdiction of the Finnish courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for UH Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS (to be completed by the data producer before passing to applicant) Dataset reference (EGA Study ID and Dataset Details) Name of project that created the dataset Names of other data producers/collaborators Specific limitations on areas of research Minimum protection measures required File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. Information Security: The User Institution shall maintain an appropriate level of information security in accordance with the provisions of the GDPR, taking into account that the Data includes data that constitutes special category data under Article 9 of the GDPR. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY UH intend to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. UH anticipate that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until six months after these data were first made available on the relevant hosting database, unless UH has provided written consent to earlier submission. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00000000029), and acknowledge its use in a form agreed by the User Institution with UH.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001003454 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00002388576 fastq.gz 4.1 GB
EGAF00002388577 fastq.gz 4.0 GB
EGAF00002388597 fastq.gz 5.6 GB
EGAF00002388598 fastq.gz 5.1 GB
EGAF00002388599 fq.gz 1.9 GB
EGAF00002388600 fq.gz 1.6 GB
EGAF00002388601 fastq.gz 3.6 GB
EGAF00002388602 fastq.gz 3.3 GB
EGAF00002388603 fq.gz 3.1 GB
EGAF00002388604 fq.gz 3.0 GB
EGAF00002388605 fq.gz 2.8 GB
EGAF00002388606 fq.gz 2.8 GB
EGAF00002388610 fastq.gz 5.0 GB
EGAF00002388611 fastq.gz 4.5 GB
EGAF00002388612 fastq.gz 3.5 GB
EGAF00002388613 fastq.gz 3.2 GB
EGAF00002388614 fastq.gz 3.4 GB
EGAF00002388615 fastq.gz 3.1 GB
EGAF00002388616 fastq.gz 5.8 GB
EGAF00002388617 fastq.gz 4.5 GB
EGAF00002388618 fastq.gz 2.8 GB
EGAF00002388619 fastq.gz 2.8 GB
EGAF00002388651 fastq.gz 6.7 GB
EGAF00002388652 fastq.gz 6.2 GB
EGAF00002388657 fastq.gz 4.3 GB
EGAF00002388658 fastq.gz 4.0 GB
EGAF00002388659 fq.gz 1.8 GB
EGAF00002388660 fq.gz 1.7 GB
EGAF00002388661 fq.gz 3.5 GB
EGAF00002388662 fq.gz 3.5 GB
EGAF00002388663 fq.gz 3.1 GB
EGAF00002388664 fq.gz 3.2 GB
EGAF00002388672 fastq.gz 4.1 GB
EGAF00002388673 fastq.gz 3.7 GB
EGAF00002388674 fastq.gz 5.3 GB
EGAF00002388675 fastq.gz 4.8 GB
EGAF00002388678 fastq.gz 4.5 GB
EGAF00002388679 fastq.gz 4.1 GB
EGAF00002388680 fastq.gz 6.7 GB
EGAF00002388681 fastq.gz 6.1 GB
EGAF00002388682 fq.gz 3.2 GB
EGAF00002388683 fq.gz 3.2 GB
EGAF00002388684 fq.gz 3.6 GB
EGAF00002388685 fq.gz 3.6 GB
EGAF00002388686 fq.gz 3.7 GB
EGAF00002388687 fq.gz 3.7 GB
EGAF00002388724 fq.gz 2.1 GB
EGAF00002388725 fq.gz 1.9 GB
EGAF00002388728 fq.gz 2.8 GB
EGAF00002388729 fq.gz 2.7 GB
50 Files (187.2 GB)